• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

6.610 +2.190 (+49.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,002,082
Open 4.520
Bid (Size) 6.340 (600)
Ask (Size) 6.420 (800)
Prev. Close 4.420
Today's Range 4.520 - 6.950
52wk Range 1.010 - 4.500
Shares Outstanding 45,052,904
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which stocks are experiencing notable movement on Friday? ↗
Today 15:00 EDT
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Topics Artificial Intelligence
News headline image
What's Behind The Surge In Zentalis Stock? ↗
Today 12:44 EDT
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) shares are surging Friday after a Guggenheim analyst raised the price target from $6 to $10. 
Via Benzinga

Performance

YTD
+382.5%
+382.5%
1 Month
+116.0%
+116.0%
3 Month
+132.7%
+132.7%
6 Month
+265.2%
+265.2%
1 Year
+465.0%
+465.0%

More News

Read More
News headline image
Top stock movements in today's session. ↗
Today 12:30 EDT
Via Chartmill
Topics Artificial Intelligence
News headline image
(ZNTL) - Analyzing Zentalis Pharma's Short Interest ↗
June 21, 2024
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. ↗
April 09, 2026
Via Chartmill
These stocks are moving in today's session ↗
April 09, 2026
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
January 09, 2026
Via Chartmill
What's going on in today's session ↗
January 09, 2026
Via Chartmill
The market is filled with gapping stocks in Friday's session. ↗
January 09, 2026
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
January 06, 2026
Via Chartmill
News headline image
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Reports Q3 2025 Earnings Beat Amidst Stock Decline ↗
November 10, 2025
Via Chartmill
Topics Earnings
News headline image
Zentalis (ZNTL) Q2 Loss Narrows 70% ↗
August 06, 2025
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
March 26, 2025
Via Benzinga
News headline image
Here are the top movers in Wednesday's session. ↗
February 05, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
February 05, 2025
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
January 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
January 29, 2025
Via Benzinga
News headline image
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers ↗
September 16, 2024
Via Benzinga
News headline image
Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL
August 19, 2024
From Newman Ferrara LLP
Via Business Wire
News headline image
Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 13, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024 ↗
August 09, 2024
Via InvestorPlace
News headline image
ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
August 01, 2024
From The Schall Law Firm
Via Business Wire
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 ↗
June 22, 2024
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 20, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 19, 2024
Via Benzinga

Frequently Asked Questions

Is Zentalis Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Zentalis Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Zentalis Pharmaceuticals, Inc. - common stock trade on?
Zentalis Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock?
The ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock is ZNTL on the Nasdaq Stock Market
What is the current price of Zentalis Pharmaceuticals, Inc. - common stock?
The current price of Zentalis Pharmaceuticals, Inc. - common stock is 6.610
When was Zentalis Pharmaceuticals, Inc. - common stock last traded?
The last trade of Zentalis Pharmaceuticals, Inc. - common stock was at 04/10/26 04:00 PM ET
What is the market capitalization of Zentalis Pharmaceuticals, Inc. - common stock?
The market capitalization of Zentalis Pharmaceuticals, Inc. - common stock is 297.80M
How many shares of Zentalis Pharmaceuticals, Inc. - common stock are outstanding?
Zentalis Pharmaceuticals, Inc. - common stock has 298M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap